MoonLake Immunotherapeutics (MLTX)
17.48
-0.32
(-1.77%)
USD |
NASDAQ |
Jun 10, 16:00
17.50
+0.02
(+0.09%)
After-Hours: 20:00
MoonLake Immunotherapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 15.02% |
| AC Immune SA | -1.32K% |
| CRISPR Therapeutics AG | -8.43K% |
| Idorsia Ltd. | -162.1% |
| ADC Therapeutics SA | -158.1% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -80.07% |
| Return on Assets | -58.69% |
| Return on Invested Capital | -64.10% |
| Return on Net Operating Assets | -888.9% |